Hydroxyethylamine-based inhibitors of BACE1: P1–P3 macrocyclization can improve potency, selectivity, and cell activity - Concepedia

Concepedia

Publication | Open Access

Hydroxyethylamine-based inhibitors of BACE1: P1–P3 macrocyclization can improve potency, selectivity, and cell activity

DOI Full Paper Access

18

Citations

31

References

2013

Year

Lewis D. Pennington, Douglas A. Whittington, Michael D. Bartberger, Steven R. Jordan, Holger Monenschein, Thomas T. Nguyen, Bryant H. Yang, Qiufen Xue, Filisaty Vounatsos, Robert C. Wahl,

Bioorganic & Medicinal Chemistry Letters

Molecular PharmacologyMedicinal ChemistryMedicineDrug DiscoveryP1–p3 MacrocyclizationPharmacological AgentPharmacotherapyAnti-cancer AgentCell ActivityDrug DevelopmentPharmacologyHydroxyethylamine-based InhibitorsPharmaceutical ChemistryNovel TherapyBiomolecular Engineering

References

	Year	Citations

Page 1

Page 1